retatrutide trial weight loss results just delivered the first top-line Phase 3 for a triple agonist in obesity β and the findings from TRIUMPH-4 are strikingπ Up to 28.7% weight loss
Description
LiverMuscle Axis: Rebuild insulin sensitivity and mitochondrial efficiency how effectively your cells turn food into usable energy
Actionable Tip: Instead of forcing a hard workout, schedule a short walk during your lunch break or in the evening

is bariatric surgery better than semaglutide for weight loss

For retatrutide, specific GI frequency data from TRIUMPH-4 are not yet fully published, but the profile is expected to be similar to other GLP-1 agents

A GIP receptor agonist exhibits beta-cell anti-apoptotic actions in rat models of diabetes resulting in improved beta-cell function and glycemic control
